Recent News

Enterprise Lending
Investor Relations
Leveraged Lending
Real Estate & ABL
October 19, 2022

Oxford Finance’s Healthcare Real Estate Group Closes Over $347 Million of Transactions During Q2 & Q3 of 2022

News | Healthcare | Real Estate & ABL
October 17, 2022

Verona Pharma Secures Debt Financing of up to $150 Million from Oxford Finance

News | Enterprise Lending | Life Sciences
September 9, 2022

Alignment Healthcare Announces Completion of Debt Refinancing

News | Healthcare | Leveraged Lending
July 6, 2022

RefleXion Announces Closing of $125M Debt Facility for Expanding Cancer Treatment

News | Enterprise Lending | Life Sciences
June 22, 2022

Antheia Announces New Financing and Plans to Construct Pilot Plant Facility for Biomanufacturing

News | Enterprise Lending | Life Sciences
June 1, 2022

Oxford Finance Announces the Closing of a $30 Million Credit Facility With Selux Diagnostics

News | Enterprise Lending | Life Sciences
May 31, 2022

Silk Road Medical Extends Cash Runway by Securing up to $250 Million in Debt Financing

News | Enterprise Lending | Life Sciences
May 5, 2022

Pliant Therapeutics Enters into $100 million Loan Facility Agreement with Oxford Finance to Support Ongoing Development of PLN-74809

News | Enterprise Lending | Life Sciences
April 25, 2022

Oxford Finance Healthcare Real Estate Q1 2022 Recap

News | Healthcare | Real Estate & ABL
April 5, 2022

Oxford Finance Announces the Closing of a $75 Million Credit Facility With Fusion Pharmaceuticals

News | Enterprise Lending | Life Sciences
March 28, 2022

Verastem Oncology Provides Financial Update to Support Development of VS-6766 and Defactinib in RAS Pathway-Driven Tumors

News | Enterprise Lending | Life Sciences
March 17, 2022

Lexicon Enters Into Loan Facility With Oxford Finance for Up to $150 Million to Support Planned Commercialization of Sotagliflozin

News | Enterprise Lending | Life Sciences

Meet the team that speaks your language.